Vie Ventures

Vie Ventures operates at the intersection of venture capital and disease philanthropy. Our team leverages decades of experience, a proven track record in life sciences venture capital, a returns-oriented approach, and a network of strategic collaborators from across the biotech and disease philanthropy ecosystems to advance life-changing therapies and cures for patients. We invest in emerging therapeutics for autoimmune and immune-mediated diseases, an area of high unmet medical need and growing scientific opportunity. Our focus is primarily on Series B and C-stage biotech companies, where thoughtful capital and strategic collaboration can meaningfully accelerate progress. Vie works in close partnership with leading disease foundations, including the Crohn’s & Colitis Foundation, Lupus Research Alliance, National MS Society, Scleroderma Research Foundation, Sjogren's Foundation, and others to align investment decisions with patient needs and scientific insight.